IN2012DN01684A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN01684A IN2012DN01684A IN1684DEN2012A IN2012DN01684A IN 2012DN01684 A IN2012DN01684 A IN 2012DN01684A IN 1684DEN2012 A IN1684DEN2012 A IN 1684DEN2012A IN 2012DN01684 A IN2012DN01684 A IN 2012DN01684A
- Authority
- IN
- India
- Prior art keywords
- malaria
- malaria infection
- mammal
- compounds
- transmission
- Prior art date
Links
- 201000004792 malaria Diseases 0.000 abstract 4
- 208000015181 infectious disease Diseases 0.000 abstract 3
- 241000124008 Mammalia Species 0.000 abstract 2
- 230000005540 biological transmission Effects 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 241000224016 Plasmodium Species 0.000 abstract 1
- 241000223960 Plasmodium falciparum Species 0.000 abstract 1
- 230000000903 blocking effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Birds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23741709P | 2009-08-27 | 2009-08-27 | |
| PCT/US2010/047019 WO2011025969A1 (en) | 2009-08-27 | 2010-08-27 | Compounds that treat malaria and prevent malaria transmission |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN01684A true IN2012DN01684A (enExample) | 2015-06-05 |
Family
ID=43628406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1684DEN2012 IN2012DN01684A (enExample) | 2009-08-27 | 2010-08-27 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US9375424B2 (enExample) |
| EP (1) | EP2470013A4 (enExample) |
| CN (1) | CN102595894A (enExample) |
| CA (1) | CA2772085A1 (enExample) |
| IN (1) | IN2012DN01684A (enExample) |
| WO (1) | WO2011025969A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9187439B2 (en) | 2011-09-21 | 2015-11-17 | Inception Orion, Inc. | Tricyclic compounds useful as neurogenic and neuroprotective agents |
| WO2013082469A2 (en) * | 2011-12-02 | 2013-06-06 | University Of Vermont And State Agricultural College | Methods and compositions for treating infections |
| WO2014031872A2 (en) * | 2012-08-23 | 2014-02-27 | The Broad Institute, Inc. | Small molecule inhibitors for treating parasitic infections |
| WO2014113495A1 (en) | 2013-01-15 | 2014-07-24 | The Trustees Of Columbia University In The City Of New York | Activation or reactivation of ache |
| EP3352764B1 (en) * | 2015-09-25 | 2020-08-05 | Sun Jet Biotechnology Inc. | Combination therapy for ev71 infection |
| EP3416972A1 (en) | 2016-02-19 | 2018-12-26 | Council of Scientific & Industrial Research | Silicon based cyclic compounds and pharmaceutical compositions for treating malaria and toxoplasmosis |
| AU2018420613B2 (en) | 2018-04-26 | 2022-12-22 | Cas Lamvac (Guangzhou) Biomedical Technology Co., Ltd. | Attenuation system and use thereof |
| CN116987040B (zh) * | 2023-06-21 | 2025-09-23 | 中国中医科学院中药研究所 | 二苯并二氮杂卓衍生物及其制备方法和应用 |
| CN117064888A (zh) * | 2023-09-26 | 2023-11-17 | 中国科学院水生生物研究所 | 氯喹或其药学上可接受的盐在制备预防生产非整倍体配子的药物中的应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5373005A (en) * | 1988-04-20 | 1994-12-13 | Merrell Dow Pharmaceuticals Inc. | Despiramine in the treatment of drug-resistant malarial infections |
| US5853739A (en) * | 1988-05-02 | 1998-12-29 | The United States Of America As Represented By The Department Of Health And Human Services | Transmission-blocking vaccine against malaria |
| DE3821392A1 (de) * | 1988-06-24 | 1989-12-28 | Nattermann A & Cie | Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on (ebselen) |
| US5021426A (en) * | 1990-02-26 | 1991-06-04 | Merck & Co., Inc. | Method of traeting malaria with cyproheptadine derivatives |
| AU691306B2 (en) * | 1994-06-17 | 1998-05-14 | F. Hoffmann-La Roche Ag | N,n'-bis(quinolin-4-yl)-diamine derivatives, their preparation and their use as antimalarials |
| JP2002541144A (ja) * | 1999-01-26 | 2002-12-03 | ダナ−ファーバー キャンサー インスティテュート，インコーポレイテッド | 医薬的に活性のある化合物及びその使用方法 |
| AU2001281403A1 (en) * | 2000-08-08 | 2002-02-18 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Compositions and methods for inhibiting transmission of malaria |
| US6881841B2 (en) * | 2000-11-22 | 2005-04-19 | Tsutomu Takeuchi | Dibenzosuberanyl piperazine derivatives and drug-resistance overcoming agents containing the derivatives |
| US7670631B2 (en) * | 2003-03-12 | 2010-03-02 | ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. | Method for the prevention of malaria infection of humans by hepatocyte growth factor antagonists |
| DE10353186A1 (de) | 2003-11-13 | 2005-06-16 | Röhm GmbH & Co. KG | Mehrschichtige Arzneiform, enthaltend eine in Bezug auf die Wirkstoffabgabe modulatorisch wirkende Substanz |
| TW200615273A (en) * | 2004-11-10 | 2006-05-16 | Nicholas Piramal India Ltd | Fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha |
| WO2008064011A1 (en) * | 2006-11-13 | 2008-05-29 | The Government Of The U.S. Of America As Represented By The Department Of Veterans Affairs | Acridone compounds |
| WO2009026858A1 (es) * | 2007-08-28 | 2009-03-05 | Centro De Quimica Farmaceutica | Derivados de la acridinona como agentes antiparasitarios, antifungicos y antivirales. |
-
2010
- 2010-08-27 WO PCT/US2010/047019 patent/WO2011025969A1/en not_active Ceased
- 2010-08-27 US US13/392,668 patent/US9375424B2/en active Active
- 2010-08-27 IN IN1684DEN2012 patent/IN2012DN01684A/en unknown
- 2010-08-27 EP EP10812670.7A patent/EP2470013A4/en not_active Withdrawn
- 2010-08-27 CN CN2010800380710A patent/CN102595894A/zh active Pending
- 2010-08-27 CA CA2772085A patent/CA2772085A1/en not_active Abandoned
-
2016
- 2016-06-24 US US15/192,779 patent/US20160303103A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US9375424B2 (en) | 2016-06-28 |
| US20160303103A1 (en) | 2016-10-20 |
| US20120196882A1 (en) | 2012-08-02 |
| CN102595894A (zh) | 2012-07-18 |
| WO2011025969A1 (en) | 2011-03-03 |
| EP2470013A4 (en) | 2013-05-01 |
| CA2772085A1 (en) | 2011-03-03 |
| EP2470013A1 (en) | 2012-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN01684A (enExample) | ||
| DOP2021000147A (es) | Combinacion terapeutica que comprende lamivudina | |
| EA201200355A1 (ru) | Способы предотвращения и лечения ишемии головного мозга | |
| IN2012DN00624A (enExample) | ||
| EA201001847A1 (ru) | Соединения и композиции, применяемые для лечения малярии | |
| NZ703064A (en) | Inhibitors of hepatitis c virus | |
| WO2010057101A3 (en) | Compounds useful as hiv blockers | |
| MX2013003634A (es) | Derivados policiclicos heterociclicos y metodos de uso de los mismos para el tratamiento de enfermedades virales. | |
| UA116765C2 (uk) | (гетеро)арилциклопропіламіни як інгібітори lsd1 | |
| EA201200098A1 (ru) | Конденсированные имидазолы и содержащие их композиции, предназначенные для лечения паразитарных заболеваний, таких как, например, малярия | |
| TN2010000137A1 (en) | Spiropyrrolidines and their use against hcv and hiv infection | |
| SG178952A1 (en) | Chemical compounds | |
| MY161495A (en) | Virus like particle compositions and methods of use | |
| EA200970542A1 (ru) | ИНГИБИТОРЫ ДЕЙСТВИЯ Akt | |
| EA201290498A1 (ru) | Терапевтические полимерные наночастицы, включающие эпотилон, и способы их получения и применения | |
| IN2012DN00971A (enExample) | ||
| SG179082A1 (en) | Method for the preparation of an influenza virus | |
| UA110213C2 (en) | Use of sigma-ligand induced opioid hyperalgesia | |
| MX2014015884A (es) | Compuestos antivirales. | |
| MY172788A (en) | Influenza vaccines | |
| WO2011153458A3 (en) | Compositions and methods for inhibition of or treatment of dengue virus infection | |
| EP2538970A4 (en) | TREATMENT OR PREVENTION OF INFECTION | |
| NZ610547A (en) | Novel monensin derivatives for the treatment and prevention of protozoal infections | |
| MX2010002679A (es) | Derivados de 4-oxoquinolina deuterados para el tratamiento de la infeccion por el virus de inmunodeficiencia humana. | |
| MX2013003903A (es) | Nuevos tratamientos de infeccion por el virus de hepatitis c. |